Ling Xu

12PUBLICATIONS
9CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 13, 2025
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report.

Mengyuan Li, Mao Ding, Yukun Hou

|May 08, 2025
HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer.

Yuan Gao, Lei Yin, Xiaojiang Duan

|May 05, 2025
Metabolic characterization and radiomics-based composite model for breast cancer immune microenvironment types using 18F-FDG PET/CT.

Yuan Gao, Zijian Fu, Xiaojuan Zhu

|Dec 17, 2024
Axillary lymph node management strategies in cN + breast cancer patients after neoadjuvant chemotherapy.

Min Gao, Xiaoxi Chen, Ling Xu

|May 16, 2024
Challenges in HER2-low breast cancer identification, detection, and treatment.

Qian Wu, Ling Xu

|Mar 01, 2024
An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.

Qijun Zheng, Huicui Yan, Yingjian He

Pageof 2

Frequent Collaborators

4 joint publications

Qian Wu

2 joint publications

Jingming Ye

2 joint publications

Meng Liu

1 joint publications

Yimin Cui